Showing results (91-100 of 352) with videos related to
Sort By:
Pageof 36
Deutsche Medizinische Wochenschrift (1946)|April 21, 2026
[Characterization of imported dengue fever cases in Germany - Results of a pilot project]Mia Wintel, Julian Bernhard, Julia S Beck, et al.Plos One|March 25, 2017
Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority studyJoshua Havumaki, Doris Hillemann, Nazir Ismail, et al.Journal of the American Geriatrics Society|March 30, 2010
Relationship between fear of falling and outcomes of an inpatient geriatric rehabilitation population--fear of the fear of fallingMichael D Denkinger, Wilmar Igl, Albert Lukas, et al.Open Forum Infectious Diseases|February 5, 2025
Programmatic Diagnostic Accuracy and Clinical Utility of Xpert MTB/XDR in Patients With Rifampicin-Resistant Tuberculosis in GeorgiaTheresa Pfurtscheller, Ana Tsutsunava, Nino Maghradze, et al.Infection|November 30, 2023
Blazing the trail for innovative tuberculosis diagnosticsSeda Yerlikaya, Tobias Broger, Chris Isaacs, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Ribosomal protection as a linezolid resistance mechanism in Mycobacterium abscessusTobias Funck, Kerry McGowen, Mark R Sullivan, et al.Eclinicalmedicine|June 11, 2025
Clinically diagnosed tuberculosis and mortality in high burden settings: a systematic review and meta-analysisBenjamin Freitag, Ayten Sultanli, Maurizio Grilli, et al.Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Integrated treatment-decision algorithms for childhood TB: modelling diagnostic performance and costsMary Gaeddert, Devan Jaganath, Abdulkadir Civan, et al.Antimicrobial Agents and Chemotherapy|March 2, 2026
Ribosomal protection as a linezolid resistance mechanism in Mycobacterium abscessusTobias Funck, Kerry McGowen, Mark R Sullivan, et al.Mbio|August 31, 2017
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care TestingSoumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, et al.Pageof 36